Climate change should be incorporated in to educational and training programmes for all health professionals to ensure they are able to urgently adapt and transition our health systems to low carbon and low waste models of care and to become climate resilient. However, the uptake [...]
Using scoping review methods, we systematically searched multiple online databases for publications in the first year of the pandemic that proposed pragmatic population or health system-level solutions to health inequities. We found 77 publications with proposed solutions to pandemic-related health inequities. Most were commentaries, letters, [...]
People often use infographics (also called visual or graphical abstracts) as a substitute for reading the full text of an article. This is a concern because most infographics do not present sufficient information to interpret the research appropriately and guide wise health decisions. The Reporting [...]
Globally, approximately one in three adults suffers from a chronic condition. People with chronic conditions are at higher risk of requiring inpatient admission and increased length of hospital stay;1 however, a significant portion of hospital admissions may be preventable.
In December 2017, the Australian National Cervical Screening Program (NCSP) changed from 2-yearly cervical cytology to 5-yearly primary human papillomavirus (HPV) testing, starting at age 25 and with an exit test when aged 70–74. Women showed limited awareness of these changes prior to their implementation. [...]
Experts developing guidelines to diagnose and treat cardiovascular diseases and diabetes are the least likely to disclose their financial ties with drug companies, a study led by Bond University in Queensland has found. The first study in Australia to examine undisclosed financial relationships between drug [...]
In September, the New York Times revealed that one of the world’s top cancer specialists had quietly received millions of dollars from drug and other companies. And what’s more, he’d failed to disclose the payments in many of his high-profile medical journal articles. A few months before [...]
There is global concern about the nature and extent of financial ties between pharmaceutical companies and health professionals, including those who develop influential clinical practice guidelines.3 In 2009, a landmark Institute of Medicine report on conflicts of interest acknowledged the importance of collaboration with industry, but [...]
Unnecessary and harmful interventions from overdiagnosis challenge the social and ethical contract that underpins healthcare. Strategies to tackle overdiagnosis from population screening should engage with the public and consider its values and concerns. Most high income countries develop evidence based policies to guide population screening using [...]